Cargando…
Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application
Treatment of amyotrophic lateral sclerosis (ALS) has been fueled, in part, by frustration over the shortcomings of the symptomatic drugs available, since these do not impede the progression of this disease. Currently, over 150 different potential therapeutic agents or strategies have been tested in...
Autores principales: | Benkler, Chen, Offen, Daniel, Melamed, Eldad, Kupershmidt, Lana, Amit, Tamar, Mandel, Silvia, Youdim, Moussa B. H., Weinreb, Orly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405320/ https://www.ncbi.nlm.nih.gov/pubmed/23199069 http://dx.doi.org/10.1007/s13167-010-0026-1 |
Ejemplares similares
-
The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
por: Kupershmidt, Lana, et al.
Publicado: (2023) -
Physiological and pathological aspects of Aβ in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators
por: Avramovich-Tirosh, Yael, et al.
Publicado: (2008) -
Recent advances in amyotrophic lateral sclerosis
por: Riva, Nilo, et al.
Publicado: (2016) -
Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives
por: Afonso, Gonçalo J. M., et al.
Publicado: (2023) -
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
por: Longinetti, Elisa, et al.
Publicado: (2019)